Cobb County has filed a lawsuit accusing several major insulin manufacturers and pharmacy benefit managers (PBMs) of ...

The lawsuit said an “unfair and deceptive conspiracy” by drug makers and drug distributors fixed prices for Georgians.

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...

Remaining MNCs include Sanofi Aventis (#13th Rank), Novartis (#21st ... GSK in anti-infectives and Abbott / Lilly / Sanofi in anti-diabetic insulin market, MNCs have largely been lagging behind ...

Sanofi’s (SNY) said FDA lifted a hold on a trial to test over-the-counter use of its Eli-Lilly (LLY)-partnered erectile ...

After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

Hoechst and Rhône-Poulenc Rorer were the two companies that merged to form Aventis. Despite Sanofi-Synthélabo’s size, the company found itself forced to partner with larger pharmaceutical ...

Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12,424.21 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...